| abstract |
The present invention relates to general formula (I), wherein the definitions of substituents X, R1 and R2 are given herein. And their physiologically acceptable salts, methods for producing these compounds and their use as pharmaceuticals. These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin dependent kinase 2). |